Integrative multi-omics identifies MSR1 as a programmed cell death and extracellular matrix hub gene in osteoarthritis with hesperidin targeting potential - Report - MDSpire
Advertisement
Integrative multi-omics identifies MSR1 as a programmed cell death and extracellular matrix hub gene in osteoarthritis with hesperidin targeting potential
Clinical Report: MSR1 as a Central Gene in Osteoarthritis Pathogenesis
Overview
This study identifies MSR1 as a key gene involved in programmed cell death and extracellular matrix dynamics in osteoarthritis (OA). The findings suggest that MSR1 plays a significant role in OA pathogenesis and highlights hesperidin as a potential therapeutic agent targeting this gene.
Background
Osteoarthritis is a prevalent degenerative joint disease that affects a significant portion of the adult population, particularly those over 65 years of age. Understanding the molecular mechanisms underlying OA is crucial for developing effective treatments. This study employs a multi-omics approach to elucidate the role of specific genes in OA, particularly focusing on programmed cell death and extracellular matrix interactions.
Data Highlights
The study identified 517 genes associated with OA, with 24 being specifically related to programmed cell death and extracellular matrix dynamics. MSR1 was found to be significantly upregulated in OA samples compared to healthy controls, indicating its potential as a biomarker for OA progression.
Key Findings
517 genes associated with osteoarthritis were identified through multi-omics analysis.
MSR1 was highlighted as a central gene involved in programmed cell death and extracellular matrix dynamics.
MSR1 expression was higher in OA samples than in healthy samples, with an AUC value greater than 0.7.
MSR1 expression correlated positively with immune populations and microenvironment scores.
Hesperidin was identified as a high-affinity MSR1-binding compound with favorable interaction stability.
In vitro studies showed that MSR1 promotes apoptosis and extracellular matrix degradation in OA-like chondrocytes.
Clinical Implications
The identification of MSR1 as a key regulator in OA pathogenesis suggests that targeting this gene may offer new therapeutic avenues. Hesperidin, as a potential modulator of MSR1, could be explored further in clinical settings to assess its efficacy in managing OA symptoms and progression.
Conclusion
This study underscores the importance of MSR1 in osteoarthritis and presents hesperidin as a promising candidate for therapeutic intervention. Further research is warranted to validate these findings and explore their clinical applications.
